Ad
Wednesday, 13 September 2017
Clinigen boost unlicensed drugs business with Quantum takeover
LONDON (Reuters) - Britain's Clinigen Group on Wednesday agreed to buy Quantum Pharma for 150.3 million pounds ($200 million), bringing together two companies that specialize in the supply of unlicensed medicines to doctors and hospitals.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment